# Sunitinib in Treating Patients With Locally Advanced Bladder Cancer

> **NCT00526656** · PHASE2 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 9 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** sunitinib malate

## Key facts

- **NCT ID:** NCT00526656
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2010-03
- **Final completion:** 2011-03
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2019-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00526656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00526656, "Sunitinib in Treating Patients With Locally Advanced Bladder Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00526656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*